Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformans
C. J. Crawford, L. Liporagi-Lopes, C. Coelho, S. R. Santos Junior, A. M. Nicola, M. P. Wear, S. Oscarson, A. Casadevall
This paper presents two semi-synthetic glycoconjugate vaccines targeting Cryptococcus neoformans GXM, showing immunogenicity and cross-reactivity in mice.
bioRxiv · Feb 2, 2024 · PreprintImmunology